These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10853648)

  • 1. Synthesis of NF-kappaB activation inhibitors derived from epoxyquinomicin C.
    Matsumoto N; Ariga A; To-e S; Nakamura H; Agata N; Hirano S; Inoue J; Umezawa K
    Bioorg Med Chem Lett; 2000 May; 10(9):865-9. PubMed ID: 10853648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naturally occurring and synthetic inhibitors of NF-kappaB functions.
    Umezawa K; Ariga A; Matsumoto N
    Anticancer Drug Des; 2000 Aug; 15(4):239-44. PubMed ID: 11200499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure-activity relationship of dehydroxymethylepoxyquinomicin analogues as inhibitors of NF-kappaB functions.
    Chaicharoenpong C; Kato K; Umezawa K
    Bioorg Med Chem; 2002 Dec; 10(12):3933-9. PubMed ID: 12413845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Late and Early Phases of Cancer Metastasis by the NF-κB Inhibitor DHMEQ Derived from Microbial Bioactive Metabolite Epoxyquinomicin: A Review.
    Lin Y; Ukaji T; Koide N; Umezawa K
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29510517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of tumor growth by NF-kappaB inhibitors.
    Umezawa K
    Cancer Sci; 2006 Oct; 97(10):990-5. PubMed ID: 16925581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of anti-rheumatic agent epoxyquinomicin B.
    Matsumoto N; Iinuma H; Sawa T; Takeuchi T
    Bioorg Med Chem Lett; 1998 Nov; 8(21):2945-8. PubMed ID: 9873652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.
    Matsumoto G; Namekawa J; Muta M; Nakamura T; Bando H; Tohyama K; Toi M; Umezawa K
    Clin Cancer Res; 2005 Feb; 11(3):1287-93. PubMed ID: 15709200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel inhibitor of p38 MAP kinase as an anti-TNF-alpha drug: discovery of N-[4-[2-ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide (TAK-715) as a potent and orally active anti-rheumatoid arthritis agent.
    Miwatashi S; Arikawa Y; Kotani E; Miyamoto M; Naruo K; Kimura H; Tanaka T; Asahi S; Ohkawa S
    J Med Chem; 2005 Sep; 48(19):5966-79. PubMed ID: 16162000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptor dependent inhibitors of NF-kappaB transcriptional activation-1 synthesis and biological evaluation of substituted 2-cyanopropanoic acid derivatives: pathway selective inhibitors of NF-kappaB, a potential treatment for rheumatoid arthritis.
    Caggiano TJ; Brazzale A; Ho DM; Kraml CM; Trybulski E; Chadwick CC; Chippari S; Borges-Marcucci L; Eckert A; Keith JC; Kenney T; Harnish DC
    J Med Chem; 2007 Nov; 50(22):5245-8. PubMed ID: 17902637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effect of a novel nuclear factor-kappa B activation inhibitor in bladder cancer cells.
    Horiguchi Y; Kuroda K; Nakashima J; Murai M; Umezawa K
    Expert Rev Anticancer Ther; 2003 Dec; 3(6):793-8. PubMed ID: 14686701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel inhibitor of I-kappaB kinase beta ameliorates experimental arthritis through downregulation of proinflammatory cytokines in arthritic joints.
    Tanaka S; Toki T; Yokoyama M; Shimizu H; Yamasaki T; Yoneda Y; Muro F; Yasukochi T; Iimura S; Morishita K
    Biol Pharm Bull; 2014; 37(1):87-95. PubMed ID: 24389485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of structurally simplified analogues of aplidinone A, a pro-apoptotic marine thiazinoquinone.
    Aiello A; Fattorusso E; Luciano P; Menna M; Calzado MA; Muñoz E; Bonadies F; Guiso M; Sanasi MF; Cocco G; Nicoletti R
    Bioorg Med Chem; 2010 Jan; 18(2):719-27. PubMed ID: 20031419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of the inhibitory effects on TNF-α-induced NF-κB activation of IMD0354 analogs.
    Li YR; Lin CC; Huang CY; Wong YH; Hsieh CH; Wu HW; Chen JJW; Wu YS
    Chem Biol Drug Des; 2017 Dec; 90(6):1307-1311. PubMed ID: 28557295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of radioactively labeled dehydroxymethyl-epoxyquinomicin, an NF-kappa B function inhibitor.
    Chaicharoenpong C; Kato K; Umezawa K
    Drugs Exp Clin Res; 2003; 29(1):1-3. PubMed ID: 12866358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking NF-kappaB as a potential strategy to treat adult T-cell leukemia/lymphoma.
    Horie R; Watanabe T; Umezawa K
    Drug News Perspect; 2006 May; 19(4):201-9. PubMed ID: 16823495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor effects of the novel NF-kappaB inhibitor dehydroxymethyl-epoxyquinomicin on human hepatic cancer cells: analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production.
    Poma P; Notarbartolo M; Labbozzetta M; Sanguedolce R; Alaimo A; Carina V; Maurici A; Cusimano A; Cervello M; D'Alessandro N
    Int J Oncol; 2006 Apr; 28(4):923-30. PubMed ID: 16525642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reprint of BMCL_19101.
    Lansdell TA; O'Reilly S; Woolliscroft T; Azevedo LM; Kahlon DK; Hovde S; McCormick JJ; Henry RW; Cornicelli JA; Tepe JJ
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6821-4. PubMed ID: 23083981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DHMEQ, a novel NF-kappaB inhibitor, induces apoptosis and cell-cycle arrest in human hepatoma cells.
    Nishimura D; Ishikawa H; Matsumoto K; Shibata H; Motoyoshi Y; Fukuta M; Kawashimo H; Goto T; Taura N; Ichikawa T; Hamasaki K; Nakao K; Umezawa K; Eguchi K
    Int J Oncol; 2006 Sep; 29(3):713-9. PubMed ID: 16865289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antineoplastic Effects of NF-κB Inhibition by DHMEQ (Dehydroxymethylepoxyquinomicin) Alone and in Co-treatment with Radio-and Chemotherapy in Medulloblastoma Cell Lines.
    Ramos PMM; Pezuk JA; Castro-Gamero AM; Oliveira HF; Scrideli CA; Umezawa K; Tone LG
    Anticancer Agents Med Chem; 2018; 18(4):541-549. PubMed ID: 29141555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and pharmacological activities of some sesquiterpene quinones and hydroquinones.
    Laube T; Bernet A; Dahse HM; Jacobsen ID; Seifert K
    Bioorg Med Chem; 2009 Feb; 17(4):1422-7. PubMed ID: 19188072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.